Trial Profile
VN-0103 Ph3 study -A randomized, observer-blind comparative study of VN-0103 and diphtheria-tetanus toxoid in Japanese adolescents
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Jan 2022
Price :
$35
*
At a glance
- Drugs Diphtheria tetanus and pertussis vaccine (Primary)
- Indications Diphtheria; Pertussis; Tetanus
- Focus Pharmacodynamics
- Sponsors Daiichi Sankyo Company; Kitasato Daiichi Sankyo Vaccine
- 26 Nov 2015 New trial record